Satoru Tsuruta

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Hayato Nagase · 3 shared papers, 2026 · strength 0.93
   • Paper Prognostic Utility of the Cachexia Index in Resectable and Borderline Resectable Pancreatic Cancer Treated with Neoadju… DOI 10.1097/mpa.0000000000002706↗
   • Paper Limited Survival Benefit of Short-Course Neoadjuvant Gemcitabine Plus Nab-Paclitaxel for Resectable Pancreatic Cancer: … DOI 10.1016/j.jss.2026.08.063↗
   • Paper Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic… DOI 10.1016/j.humpath.2026.106238↗
2. Kenichi Hakamada · 3 shared papers, 2026 · strength 0.93
   • Paper Prognostic Utility of the Cachexia Index in Resectable and Borderline Resectable Pancreatic Cancer Treated with Neoadju… DOI 10.1097/mpa.0000000000002706↗
   • Paper Limited Survival Benefit of Short-Course Neoadjuvant Gemcitabine Plus Nab-Paclitaxel for Resectable Pancreatic Cancer: … DOI 10.1016/j.jss.2026.08.063↗
   • Paper Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic… DOI 10.1016/j.humpath.2026.106238↗
3. Yusuke Wakasa · 3 shared papers, 2026 · strength 0.93
   • Paper Prognostic Utility of the Cachexia Index in Resectable and Borderline Resectable Pancreatic Cancer Treated with Neoadju… DOI 10.1097/mpa.0000000000002706↗
   • Paper Limited Survival Benefit of Short-Course Neoadjuvant Gemcitabine Plus Nab-Paclitaxel for Resectable Pancreatic Cancer: … DOI 10.1016/j.jss.2026.08.063↗
   • Paper Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic… DOI 10.1016/j.humpath.2026.106238↗
4. Keinosuke Ishido · 3 shared papers, 2026 · strength 0.93
   • Paper Prognostic Utility of the Cachexia Index in Resectable and Borderline Resectable Pancreatic Cancer Treated with Neoadju… DOI 10.1097/mpa.0000000000002706↗
   • Paper Limited Survival Benefit of Short-Course Neoadjuvant Gemcitabine Plus Nab-Paclitaxel for Resectable Pancreatic Cancer: … DOI 10.1016/j.jss.2026.08.063↗
   • Paper Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic… DOI 10.1016/j.humpath.2026.106238↗
5. Taiichi Wakiya · 1 shared paper, 2026 · strength 0.32
   • Paper Limited Survival Benefit of Short-Course Neoadjuvant Gemcitabine Plus Nab-Paclitaxel for Resectable Pancreatic Cancer: … DOI 10.1016/j.jss.2026.08.063↗
6. Kenta Ogasawara · 1 shared paper, 2026 · strength 0.26
   • Paper Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic… DOI 10.1016/j.humpath.2026.106238↗
7. Tadashi Yoshizawa · 1 shared paper, 2026 · strength 0.26
   • Paper Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic… DOI 10.1016/j.humpath.2026.106238↗
8. Hiroshi Kijima · 1 shared paper, 2026 · strength 0.26
   • Paper Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic… DOI 10.1016/j.humpath.2026.106238↗
9. Yoshiki Nishiyama · 1 shared paper, 2026 · strength 0.26
   • Paper Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic… DOI 10.1016/j.humpath.2026.106238↗
10. Shintaro Goto · 1 shared paper, 2026 · strength 0.26
    • Paper Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic… DOI 10.1016/j.humpath.2026.106238↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.